BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8573556)

  • 1. Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group.
    Leor J; Goldbourt U; Rabinowitz B; Reicher-Reiss H; Boyko V; Kaplinsky E; Behar S
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):723-9. PubMed ID: 8573556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Leor J; Goldbourt U; Behar S; Boyko V; Reicher-Reiss H; Kaplinsky E; Rabinowitz B
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):609-17. PubMed ID: 8547212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is digoxin an independent risk factor for long-term mortality after acute myocardial infarction?
    Køber L; Torp-Pedersen C; Gadsbøll N; Hildebrandt P; Høilund-Carlsen PF
    Eur Heart J; 1994 Mar; 15(3):382-8. PubMed ID: 8013513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
    Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are coronary patients at higher risk with digoxin therapy? An ongoing controversy.
    Reicher-Reiss H; Jonas M; Boyko V; Shotan A; Goldbourt U; Behar S
    Int J Cardiol; 1999 Feb; 68(2):137-43. PubMed ID: 10189000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intravenous digoxin on the occurrence of ventricular tachyarrhythmias in acute myocardial infarction in man.
    Reicansky I; Conradson TB; Holmberg S; Rydén L; Waldenström A; Wennerblom B
    Am Heart J; 1976 Jun; 91(6):705-11. PubMed ID: 775954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When, and when not, to use digoxin in the elderly.
    Gosselink AT; van Veldhuisen DJ; Crijns HJ
    Drugs Aging; 1997 Jun; 10(6):411-20. PubMed ID: 9205847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission predictors of in-hospital mortality and subsequent long-term outcome in survivors of ventricular fibrillation out-of-hospital cardiac arrest: a population-based study.
    Bunch TJ; West CP; Packer DL; Panutich MS; White RD
    Cardiology; 2004; 102(1):41-7. PubMed ID: 14988618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.
    Maggioni AP; Zuanetti G; Franzosi MG; Rovelli F; Santoro E; Staszewsky L; Tavazzi L; Tognoni G
    Circulation; 1993 Feb; 87(2):312-22. PubMed ID: 8093865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discharge heart rate and mortality after acute myocardial infarction.
    Seronde MF; Geha R; Puymirat E; Chaib A; Simon T; Berard L; Drouet E; Bataille V; Danchin N; Schiele F
    Am J Med; 2014 Oct; 127(10):954-62. PubMed ID: 25004457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Bauersachs J; Pitt B; Fay R; Ambrosio G; Solomon SD; Dickstein K; Zannad F
    Clin Res Cardiol; 2017 Sep; 106(9):722-733. PubMed ID: 28455597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-based differences in the effect of digoxin for the treatment of heart failure.
    Rathore SS; Wang Y; Krumholz HM
    N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group.
    Tanne D; Goldbourt U; Zion M; Reicher-Reiss H; Kaplinsky E; Behar S
    Stroke; 1993 Oct; 24(10):1490-5. PubMed ID: 8378952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM; Hille DA; Wachtell K; Kjeldsen SE; Boman K; Dahlöf B; Devereux RB
    J Hypertens; 2015 Jul; 33(7):1480-6. PubMed ID: 25799208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.